Open-label olanzapine in obsessive-compulsive disorder refractory to antidepressant treatment

被引：23
|
作者：
Crocq, MA [1 ]
Leclercq, P [1 ]
Guillon, MS [1 ]
Bailey, PE [1 ]
机构：
[1] Ctr Hosp, F-68250 Rouffach, France
来源：
EUROPEAN PSYCHIATRY | 2002年 / 17卷 / 05期
关键词：
olanzapine; obsessive-compulsive disorder; augmentation therapy; treatment-unresponsive OCD;
D O I：
10.1016/S0924-9338(02)00673-9
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：296 / 297
页数：2
相关论文
共 50 条
  • [21] Antidepressant augmentation with low-dose olanzapine in obsessive-compulsive disorder
    Marusic, A
    Farmer, A
    BRITISH JOURNAL OF PSYCHIATRY, 2000, 177 : 567 - 567
  • [22] Effectiveness of olanzapine treatment for severe obsessive-compulsive disorder
    Marazziti, D
    Pallanti, S
    AMERICAN JOURNAL OF PSYCHIATRY, 1999, 156 (11): : 1834 - 1835
  • [23] Repetitive transcranial magnetic stimulation on supplementary motor area in the treatment of refractory obsessive-compulsive disorder: open-label pilot study
    Koo, B. H.
    Seo, W. S.
    Cheon, E. J.
    Kim, H. K.
    Lee, Y. J.
    Lee, S. W.
    Yun, S. H.
    Lee, G. W.
    Choi, J. H.
    Keum, M. S.
    Choi, W. S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S619 - S620
  • [24] Refractory obsessive-compulsive disorder: a challenging treatment
    Ramos, A. L.
    Salgado, H.
    EUROPEAN PSYCHIATRY, 2022, 65 : S295 - S295
  • [25] Citalopram in refractory obsessive-compulsive disorder: an open study
    Marazziti, D
    Dell'Osso, L
    Gemignani, A
    Ciapparelli, A
    Presta, S
    Di Nasso, E
    Pfanner, C
    Cassano, GB
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2001, 16 (04) : 215 - 219
  • [26] An open-label trial of riluzole, a glutamate antagonist, in children with treatment-resistant obsessive-compulsive disorder
    Grant, Paul
    Lougee, Lorraine
    Hirschtritt, Matthew
    Swedo, Susan E.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (06) : 761 - 767
  • [27] Topiramate augmentation in treatment-resistant obsessive-compulsive disorder: A retrospective, open-label case series
    Van Ameringen, M
    Mancini, C
    Patterson, B
    Bennett, M
    DEPRESSION AND ANXIETY, 2006, 23 (01) : 1 - 5
  • [28] Pharmacogenetics of Antidepressant Treatment Response in Obsessive-Compulsive Disorder
    Zai, Gwyneth
    Cappi, Carolina
    Goncalves, Vanessa
    Shavitt, Roseli
    Miguel, Euripedes Constantino
    Richter, Margaret A.
    Kennedy, James L.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 8 - 9
  • [29] Bupropion for patients with obsessive-compulsive disorder: An open-label, fixed-dose study
    Vulink, NCC
    Denys, D
    Westenberg, HGM
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (02) : 228 - 230
  • [30] Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder
    Koran, LM
    Ringold, AL
    Elliott, MA
    JOURNAL OF CLINICAL PSYCHIATRY, 2000, 61 (07) : 514 - 517
12345